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Abstract. In this paper, we present a heart disease prediction use case showing
how synthetic data can be used to address privacy concerns and overcome con-
straints inherent in small medical research data sets. While advanced machine
learning algorithms, such as neural networks models, can be implemented to im-
prove prediction accuracy, these require very large data sets which are often not
available in medical or clinical research. We examine the use of surrogate data
sets comprised of synthetic observations for modeling heart disease prediction.
We generate surrogate data, based on the characteristics of original observations,
and compare prediction accuracy results achieved from traditional machine learn-
ing models using both the original observations and the synthetic data. We also
use a large surrogate data set to build a neural network model (Perceptron) and
compare the prediction results to the traditional machine learning algorithms (Lo-
gistic Regression, Decision Tree and Random Forest). Using traditional Machine
Learning models with surrogate data, we achieved improved prediction stability
within 2 percent variance at around 81 percent using ten fold validation. Using
the neural network model with surrogate data we are able to improve the accuracy
of heart disease prediction by nearly 16 percent to 96.7 percent while maintaining
stability at 1 percent. We find the use of surrogate data to be a valuable tool, as a
means to anonymize sensitive data and improve classification prediction.
1 Introduction
Traditional classification algorithms such as logistic regression and decision trees have
historically been employed to design prediction models for medical data sets [1]. These
approaches can provide very good accuracy of classification prediction. As machine
learning algorithms become more popular and accessible, researchers may be tempted
to apply neural network models to medical data sets in an attempt to improve classifi-
cation prediction accuracy. However, medical data are often constricted by smaller sets
of observations than what is usually preferred to allow for sufficient training and testing
of models built using machine learning algorithms [2]. Without sufficiently sized data
sets, it is very difficult to determine if a model is generalizable to previously unseen sets
of data [3].
Using synthetic data to overcome constraints inherent in small medical research
data sets could be a solution to protect patient privacy and allow for application of
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machine learning algorithms. With tools such as the Synthpop package in R, researchers
are able to efficiently generate extremely large data sets with the same characteristics
of the original data to be used in machine learning algorithms. The larger data sets
allow for sufficiently sized training and testing partitions which enable the machine
learning algorithm to learn from experience by exposure to a large set of observations,
and then to be tested upon another large set of observations that have not previously
been introduced to the model.
In this paper, we examine the application of synthetic data generation to a heart
disease prediction problem. Heart disease prediction is a well-studied classification
problem and prior analyses serve as adequate baselines for our review. This analysis
is completed in three stages. In stage one, we examine previously published results and
replicate logistic regression, decision tree, and random forest models using the Cleve-
land Heart Disease data, as points of reference for our synthetic data research. In stage
two, a surrogate data set of 50,000 observations is generated, based on the character-
istics of the Cleveland data, using the Synthpop package in R. This surrogate data set
serves as a stand in for the original observations. We carefully compare the surrogate
data set to the original observations to determine that the original characteristics are
maintained. We show that the distribution of the variables is consistent between the
surrogate and original observations.
Using the synthetic data, we train and validate the Machine Learning Models then
compare the prediction outcome accuracy to that using the original observations. Once
satisfied with the consistency of classification prediction between the original data set
and the surrogate data set, we generate an expanded surrogate data set in stage three.
While based on the Cleveland data set, this expanded set contains previously unstudied
attributes. This expanded data set is used to test and train a neural network model using
the Keras API for Python, having partitioned the synthetic data into large testing and
training subsets. We then compare the outcome of the prediction accuracy of the neu-
ral network model to the traditional logistic regression models. We find that using the
expanded surrogate data set to build a neural network model results in the best classi-
fication prediction accuracy and stability. We pursue this model only after examining
the synthetic data output and comparing it to the original observations. Finding that the
characteristics of the original Cleveland data are maintained in the surrogate data sets,
we find the use of surrogate data to be appropriate.
We conclude that the Synthpop package is a viable option to generate synthetic
observations which can conceal sensitive data points and be used for deep learning. We
are able to improve the accuracy of heart disease classification prediction by nearly 16
percent, using this approach. Based on these results, we consider this method to be a
useful approach when analyzing relatively small clinical data sets.
The remainder of this paper is organized as follows. In section 2, we introduce the
heart disease prediction problem, and describe the medical condition and risk factors.
We also examine prior heart disease prediction analyses, noting prediction accuracy
and modeling algorithms employed. In section 3, we describe the well-studied Cleve-
land heart disease data set, including the explanatory variables. Our design methods are
presented in section 4 with a detailed explanation of the Synthpop package and dis-
cussion of our workflow process, describing each stage of our analysis. Our results are
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presented in section 5, followed by the related analyses in section 6. In section 7, we of-
fer a discussion of ethical concerns specific to medical data sets and the use of synthetic
data. In section 8 we discuss potential research work to be done in the future using
surrogate data generated from geographically diverse patient data sources. Finally, in
section 9 we conclude on the work that is presented in this paper.
2 Coronary Heart Disease and Prediction
Heart Disease is a cardiovascular condition that affects 11.7 percent of American adults,
with estimated costs, including healthcare, medications and lost productivity, of approx-
imately 200 billion dollars [5]. Coronary Heart Disease (CHD), the most common type
of heart disease, is a condition where the blood flow in the coronary arteries is im-
paired due to the narrowing effect of plaque buildup within the coronary arteries. There
are well known causes to this condition including diet high in fat and cholesterol, in-
adequate physical activity, excess body weight, and tobacco and alcohol use. Without
early detection and clinical intervention, studies show that almost half of the patients
diagnosed with CHD will eventually die of the disease [7]. According to the National
Center for Health Statistics report of 2016, heart disease was the leading cause of death
causing 23.4 percent of the total reported deaths in 2015[8].
According to the American Heart Association1, the terms Coronary Arterial Disease
(CAD) and CHD are frequently used interchangeably. However, to be specific, a diag-
nosis of CAD is often a prequel to a diagnosis of the more general CHD[9]. In medical
practice, CHD is a common term for the buildup of plaque in the arteries leading to and
from the heart where restricted blood flow of the heart muscle, known as ischemia, will
eventually lead to a heart attack.
2.1 Risk Factors for Heart Disease
There are multiple risk factors that can contribute to the development of CHD. A sum-
mary of the significant factors is shown in Table 1 below.
Although age, gender and family history are factors that cannot be changed or con-
trolled, acknowledging them as risk factors can empower an individual to take initiative
in monitoring for the controllable factors. Risk of CHD increases with age and positive
family history of heart disease. In addition, men have more heart attacks than women
and heart attacks in men occur earlier in age than women [10].
Many risk factors are routinely monitored by physicians. Blood pressure readings
are measured at almost every clinic encounter. High blood pressure is one of the side
effects of restricted blood flow. Arterial blockage which restricts blood flow in the blood
vessels causes Hypertension due to increased resistance in blood flow when the heart
is pumping. Blood pressure measurements higher than 140/90 are associated with in-
creased heart disease risk.
Cholesterol readings are also frequently monitored for patients. Low Density Lipopro-
tein (LDL) Cholesterol, also known as the bad cholesterol, is carried in the blood stream
1 Coronary Artery Disease - Coronary Heart Disease. http://www.heart.org/en/health-
topics/consumer-healthcare/what-is-cardiovascular-disease/coronary-artery-disease
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Table 1. Risk Factors Associated with Heart Disease
Risk Factor Normal Range Controllable
High LDL <130 mg/dL depending on risk Yes
Low HDL >60 mg/dL, 40 for men, 50 for women Yes
Hypertension <140/90 mm Hg Yes
Family History N/A No
Cigarette Smoking N/A Yes
Age <45 to 55 (low risk) No
Obesity <25 Body Mass Index (BMI) Yes
Gender <45 for men, <55 for women (low risk) No
and is indicated by the marker LDL-C. The amount of cholesterol carried in the blood-
stream gives important information about the risk of developing CHD. Levels of LDL-C
greater than 130 mg/dL are associated with increased risk of CHD. Another risk factor
is low levels of the High Density Lipoprotein (HDL) cholesterol also known as the good
cholesterol. Levels of HDL cholesterol under 60 mg/dL also indicate increased risk for
CHD [6].
These clinical measurements can often be managed by a patient in order to reduce
the risk of CHD. Hypertension, high LDL-C and low HDL-C can be controlled by diet,
medication or physical activity. Regular physical activity has many benefits including
stress reduction, weight control and lowering high blood pressure.
There are a few key risk factors that can be influenced by lifestyle choices, including
cigarette smoking and obesity. Smoking is a risk factor and is highly correlated to high
blood pressure. Smoking causes hardening of the arteries and causes blood pressure to
rise. Avoidance of tobacco smoke, which may lower blood pressure, is yet another risk
factor that can be improved by the patient. Additionally, the condition of obesity can be
improved with diet and physical activity [10].
2.2 Studies in Heart Disease Prediction
CHD prediction algorithms and data mining techniques have been available since the
1960s. As with many medical concerns that potentially impact the health of a large pop-
ulation of individuals, prediction of heart disease is a topic that has been well studied.
In a 2010 publication, K. Srinivas et al. [11] applied data mining techniques to
clinical documentation for arterial blockage measurements to predict diseased arteries.
Their study brings attention to the vast amount of clinical data that are available within
a patient medical record and considers, more broadly, how to utilize these data points to
identify unseen patterns and unlock insights that can impact and improve patient health.
In their study, the percentage of arterial blockage was classified as healthy or non-
healthy. For three of the arteries (Right Coronary Artery, Left Anterior Descending,
and Left Circumflex) the cut-off values were set at 50 percent, with 70 percent or higher
representing significant disease. For the Left Main Coronary Artery, the cutoffs were set
at 30 percent and 50 percent, respectively. This adjustment was due to the presumption
that blockage in this artery is likely to produce more disease than the others. Ultimately,
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the authors identify a Naive Bayes model that can be used to predict heart disease with
accuracy in the low to mid 80 percent range.
In a 2011 publication, Jabbar et al. utilized the Cleveland Heart Disease Data set
to examine association rule techniques in predicting heart disease [12]. Their study
transformed the measurements from the Cleveland data into binary classifications of
variables. For example, where the data contained a specific cholesterol measurement
for the subject (e.g., 200, 205, 262), the researchers transformed that value into either a
0 or 1 based on their established criteria. In their study, cholesterol values greater than
240 would have a binary value of 1 and those less than that threshold would have a
value of 0.
This process of scoring clinical results enabled the researchers to apply clustering
techniques and develop a Cluster Based Association Rule Mining Based on Sequence
Number (CBARBSM) model. The model ultimately examined frequent item sets and
results concluded that the association rule for heart disease includes the following: age
greater than 45, systolic blood pressure greater than 120, maximum heart rate greater
than 100 and old Peak (stress test depression) greater than 0 and Thallium (measurement
of defect) greater than 3.
In 2012, Shouman et al., researchers built upon prior studies to combine decision
tree techniques with k-means clustering to determine if heart disease prediction accu-
racy of existing models can be improved [13]. In the Shouman study, the researchers
found that the best technique was to apply the k-means clustering to the age variable and
use the remaining 13 attributes for the decision tree. Their results showed that their opti-
mal design, using two clusters, produced approximately 83.9 percent accuracy of heart
disease prediction. The researchers opined that their model be improved by adding more
clusters or application to a larger data set.
A 2015 publication by El-Bialy et al. reinforces the motivation for the volume of
research around the topic of cardiovascular disease, as it notes the fatality of the con-
dition in that the illness causes over one million deaths each year and that almost one
half of individuals with the condition will eventually die from the disease [7]. The study
also discusses challenges associated with accumulating and using clinical data. Some of
these include the sparse nature of the data, measurement errors, recording inaccuracies,
and variations in professional interpretation, etc. As researchers, we also recognize this
problem and acknowledge the delicate balance between the desire to utilize all the data
that are available and simultaneously, build the most accurate model for use.
The authors concluded that applying the same machine learning techniques to dif-
ferent data sets can produce different results and noted that the accuracy of the models
developed using C4.5 and fast decision trees were in the mid to high 70 percent range
when applied to four distinct data sets. Table 2 below summaries the findings of these
prior research studies.
In all of the above studies, the researchers’ focus was mainly on the machine learn-
ing algorithms used in predicting heart disease. Machine learning algorithms such as
logistic regression, decision tree, K-means clustering and fuzzy rule based models were
used in their analysis. These models used the processed version of the Cleveland dataset
and the models were fine tuned to maximize the accuracy metrics of the models [14].
These studies did not appear to consider techniques that could be applied to the data
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Table 2. Summary of Prior Heart Disease Prediction Studies
Research Study Year Accuracy
K.Srinivas B.Kavihta Rani Dr. A.Govrdhan 2010 Low to mid 80%
Mai Shouman, Tim Turner, Rob Stocker 2012 83.90%
Randa El-Bialy, Mostafa A. Salamay, et al. 2015 Mid to high 70%
set used by the models in order to improve the accuracy and stability of the prediction
accuracy.
2.3 Challenges Associated with Medical Data Sets
Application of today’s Machine Learning techniques in heart disease prediction have
challenges in data size and confidentiality matters. Processing times for statistical mod-
els that are core to modern day machine learning classification and Artificial Neural
Network (ANN) algorithms have been greatly reduced thereby allowing for deeper anal-
ysis and enhanced validation techniques [7]. However, application of machine learning
techniques often require very large data sets, much larger than what is traditionally
available from medical research experiments, where observation sizes are constrained
by cost, complexity and patient confidentiality compliance requirements. Such small
datasets are typical in healthcare where they are adequate for human comprehension
but insufficient in volume for machine learning models [2]. One reason for the small
size of medical data sets is due to the lack of centralized medical databases. Hospitals,
insurance companies, clinics and research organizations all maintain and protect their
own patient databases. Patient privacy laws are the main reason for this fragmentation
[22]. These data sets are categorized as small-data and often come in less than 500 ob-
servations and can be as small as 10 observations. Machine learning algorithms such
as ANN are built through a process of model training where the machine is trained to
learn by experience and exposure to data observations. The models are then tested using
previously unseen data to assess model performance and ensure trained models can be
generalized to new sets of data.
A novel solution for satisfying data volume requirements for machine learning mod-
els was developed by Torgyn Shaikhina and Natalia A. Khovanova in a 2016 publica-
tion titled Handling Limited Datasets with Neural Networks in Medical Applications:
A Small-Data Approach [3]. In this research, a framework for generating surrogate data
from small data sets (as small as ten observations) was developed and validated using
neural network techniques. This technique utilizes multiple runs of 2000 neural net-
works in order to generate robust data sets that mimic the characteristics of the real
data set and provides adequate data volumes to satisfy modern machine learning based
prediction. The number of neurons required for this technique requires large computing
resources therefore, in this experiment, we chose an alternative solution for surrogate
data generation.
There are several tools available for surrogate data generation. Synthpop is an R lan-
guage library that provides data synthesis and data comparison functions [26]. Simpop
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is also an R language library that provides surrogate data synthesis utilizing S4 class
implementation, but without the comparison tools provided by Synthpop to compare
the seed data to the surrogate data [27]. There are numerous other methods that use the
R ”boot” package (bootstrap) to re-sample small data sets for surrogate data generation,
but this was found to be a low level implementation and lacking built-in comparison
tools like those provided by Synthpop [28]. Synthpop was chosen as the tool for surro-
gate data generation in this study because of the ease of use and the built-in tools that
provide comparisons of the seed data to the surrogate data characteristics.
3 Heart Disease Data Set
Our analysis was performed using data from the Heart Disease Database available
from the UCI Repository (Center for Machine Learning and Intelligent Systems) [14].
This data has been available since 1988, and is considered the gold standard in heart
disease prediction research because of its availability and widespread use in research
[13][24][25].
There are four available database categories as shown in Table 3 below. Of these
four sources, the Hungarian, Switzerland, and Long Beach data sets have many missing
values; therefore, the Cleveland dataset has been used the most due to its completeness
of observations [15]. Although well documented in previous studies, we explored all of
these data sets during the data preparation stage and have chosen to utilize the Cleveland
data set because it has the least number (only six observations) of missing data.
Table 3. UCI Repository for Machine Learning Heart Disease Databases
Database Donor Author Instances
Cleveland Cleveland Clinic Foundation Robert Detrano, M.D., Ph.D. 303
Hungarian Hungarian Institute of Cardiology, Budapest Andras Janosi, M.D. 294
Switzerland University Hospital, Zurich, Switzerland William Steinbrunn, M.D. 123
Long Beach V.A. Medical Center, Long Beach Robert Detrano, M.D., Ph.D. 200
The four Heart Disease data sets are available in raw and processed formats2. The
raw format is space delimited text and where there is missing data, a ”-9” was inserted.
The Cleveland raw data set contains 76 attributes, but half (38) of the attributes are not
usable due to missing or undefined data. The number of final usable records from the
raw data set after the data cleanup was 282 records with 38 attributes. The processed
data (the Cleveland 14 data set) is a comma delimited text file and has been reduced
to 14 attributes as a result of past research [7]. In the processed databases, the missing
data encoding (-9) still exists. Of the four processed databases, the Cleveland 14 data is
the most complete with only 6 records of missing data making the total usable size 297
records with 14 attributes.
2 Relevant Information (4): http://archive.ics.uci.edu/ml/machine-learning-databases/heart-
disease/heart-disease.names
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Most of the recent research utilizes the processed Cleveland database containing 14
attributes (Table 4) [7]. The response variable (diag) indicates the presence or absence of
heart disease. In the raw data, the values range from zero (0) to four (4). Zero indicates
less than fifty percent arterial blockage and is classified as no disease, while one to four
(1-4) is an indication of the degree of arterial blockage of over fifty (50) percent. For
most studies the values of 1 through 4 are coded into a one (1) value so the prediction
is based solely on whether heart disease is present or not. In addition to the response
variable, there are 13 features used in this study from the Cleveland data set including
age, sex, chest pain, resting blood pressure, cholesterol, fasting blood sugar, resting
electrocardiography (ECG), maximum heart rate from Thallium test, exercise induced
angina, ST depression (an ECG reading indicating blood flow), the slope of the ST
depression, the number of blood vessels colored by fluoroscopy, and the heart defect
status code. Table 4 lists the variables and descriptions. In this study, we refer to the
processed Cleveland dataset as Cleveland 14.
All four datasets include variables which are patient readings collected from what
is known as Stress or Exercise Test. Exercise Testing is performed by a Cardio Imaging
Technician at the supervision of a Cardiologist where the patients heart rate is elevated
by means of treadmill activity or by injection of a drug that makes the heart pump
faster. The patients heart pumping activity is monitored both at rest and with elevated
heart rate. Thallium, which is a radioactive material, is injected into the patients blood
stream so that the medical imaging equipment can capture the patients blood flow and
heart activity both at rest and with elevated heart rate [10]. Some Stress Test related
metrics such as maximum heart rate, oldpeak and slope (electrocardiogram readings)
are captured in the Cleveland 14 dataset.
Table 4. Cleveland 14 Data Set Variables
Attribute Description
age Age in years; continuous
sex Gender; categorical
chest pain Scale of 1 to 4; categorical
resting bp Diastolic blood pressure; continous (mmHg)
cholesterol Total Cholesterol; continuous (mg/dl)
fast bsugar Scale of 0 to 1; categorical
resting ecg Scale of 0 to 2; categorical
max hrate max heartrate from thalium test; continuous
exer angina Scale of 0 to 1; categorical
Oldpeak ST depression relative to rest; continuous
Slope Scale of 1 to 3; categorical
ca mavessel Scale of 0 to 4; categorical
heart def status One of 3 values (per thalium test); categorical
diag Response variable; 0 no disease, 1 disease; categorical
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Management of the missing data was done in two ways. In the early stages of this
study, a decision was made not to impute or substitute the missing data in the processed
Cleveland data set in order to be consistent with the data used in past heart disease
prediction studies [13]. In the final stage of this study, the raw Cleveland data (no com-
ponent reduction) set was used to take advantage of the larger number of variables to
train the Perceptron Neural Network Model. There were five (5) records with missing
data and the missing data were filled in with imputed values (mean value of the at-
tribute column). After data cleaning, the original 76 variables were reduced to 38 due
to columns with all missing or unknown data. The final shape of the raw Cleveland data
set after data cleaning was 38 x 282 (38 attributes and 282 samples).
The volume size of both the Cleveland 14 and the raw Cleveland data sets, which
contain less than 300 records, are small and not ideal for stable performance of machine
learning prediction models. This is because the training and validation steps for machine
learning models involve splitting the data set into training and testing partitions. In a
typical 10 fold cross validation process, the data set can be split where 80% of the
records are used to train the models and 20% for testing. The training and test sets are
further split into 10 partitions during the cross validation stage in order to observe the
stability of the model. It is expected that the small volume size of both the Cleveland 14
and the raw Cleveland data sets will be problematic in the training and cross validation
process and will result in unstable performance measurements. In order to introduce
stability to the training and cross validation stages, we applied the use of data synthesis
to produce surrogate data in this study.
4 Methods and Experiments
The usefulness of a good heart disease prediction model depends largely on its accuracy
and stability. To achieve this, we divided this experiment into three (3) stages (Figure 1).
In stage 1 of the experiment we established baseline models and their results. The main
objective of Stage 1 was to validate and compare the accuracy and stability of the results
of our own machine learning models with those of the results in prior research studies
using the Cleveland 14 dataset [13][25][24]. In Stage 2, we introduced a variation of
the Cleveland 14 dataset by generating synthetic data based on the Cleveland 14 data
using the R Programming Language and the Synthpop Library. We used Synthpop to
generate fifty thousand (50,000) records that mimic the characteristics of the Cleveland
14 data (containing 297 records). We then used this larger surrogate dataset to train
and test the previous logistic regression, decision tree and random forest models. The
purpose of Stage 2 was to see if there was an improvement in accuracy and stability
of the same machine learning models by comparing the results to the baseline in Stage
1. In Stage 3 of this experiment, we generated sixty thousand records from the raw
Cleveland dataset and used the surrogate data to train and test an ANN model of the
Perceptron Forward and Back Propagation algorithm type. ANN models in general have
the advantage of simpler feature selection because the models make no assumptions
about the data input. We used the raw Cleveland dataset with 37 Explanatory Variables
and 1 Response Variable. The Perceptron model performs well with large datasets, so
a surrogate dataset of 60,000 records was generated from the raw Cleveland Dataset
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(shape of 38 X 282). The purpose of Stage 3 was to compare the accuracy and stability
of the Perceptron model to the Stage 1 and Stage 2 model accuracy and stability.
Fig. 1. Machine Learning Experiment Stages
4.1 Synthetic Data Generation using Synthpop
As previously mentioned, in stages 2 and 3, we expanded the volume of the data by gen-
erating a surrogate dataset from the original data. This was accomplished by a process
of data synthesis using the R language Synthpop library. Synthpop generates synthetic
data from the original dataset and produces a surrogate dataset that mimics the charac-
teristics of the original dataset. The resulting surrogate dataset volume can be adjusted
to a higher or lower volume to increase or decrease the total number of records in the
surrogate dataset. The motivation behind the creation of Synthpop by its authors was to
conceal confidential data by generating synthetic versions of the data without disclosing
real data values while preserving the characteristics and the relationships between the
variables [26].
Synthpop produces synthetic data using statistical techniques. The generation of the
synthetic data is done via the function syn(). At its simplest usage, the function syn()
only requires the argument data which is a data frame or matrix that contains the orig-
inal data and can be supplied with the k argument that specifies the record size of the
synthetic data. Other arguments specify random number seed and drop.not.used
which if TRUE, variables not used in the synthesis are not saved in the synthesized data.
Internally, the synthetic data is produced column by column based on the estimated
distribution of the original data’s column. The creation of the synthetic data is done by
10
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projecting and fitting general linear/logistic models using the original data and by im-
plementing Classification and Regression Trees (CART). The projection of the original
data via the general linear/logistic models into surrogates of varied sizes allows for vali-
dation of the synthetic dataset by fitting the synthetic data via the general linear/logistic
model and comparing the statistical characteristic to the original dataset via the function
compare(). The compare() function plots a frequency plot of the percentage makeup
of the original data versus the synthetic data. Depending on the argument passed to
compare(), a comparison of the coefficient or Z confidence interval can also be plot-
ted. The utility of the compare()function was used in stages 2 and 3 to demonstrate
that the data characteristics of the Surrogate data set were preserved.
4.2 Model Evaluation Metrics
In all three stages of the experiment, three measures were used to assess the machine
learning or classifier models’ predictive capabilities. The first metric was the accuracy
classification score. The accuracy score measured the fraction of the classifier’s predic-
tions that are correct and is expressed by the following formula:
accuracy(y, yˆ) = 1nsamples ∑
nsamples−1
i=0 1(yˆ= yi)
The second metric is the precision or confidence. Precision is the proportion of pre-
dicted positive cases that are real positives and is expressed by the following formula:
precision= TruePositivesTruePositives+FalsePositives
The third metric is the recall or sensitivity. Recall measures the coverage of real positive
cases as influenced by the number of false negative cases. The formula for recall is
expressed as:
recall = TruePositivesTruePositives+FalseNegatives
All three metric values range from zero (0) to one (1). The closer the value is to one,
the better the performance.
4.3 Stage 1
The objective of Stage 1 was to establish a baseline of the heart disease prediction
metrics based on past research work. The baseline was established by using the Cleve-
land 14 data set the way it was used in some of the previous studies [13][24][25]. In
the Shouman et al. study, a K-means clustering technique was used to pre-process the
Cleveland 14 data using various centroid selection methods prior to using the Naive
Bayes algorithm resulting in accuracy ranges from the high 70% to mid 80% range. We
observed that although the results of the study showed improvement in the accuracy by
applying the K-means preprocessing, the stability of the prediction metrics exhibited a
wide range of results when selecting the number of clusters. In our study, the models
used in stage 1 were from the Scikit-learn Python library. Three different algorithms
were used from Scikit-learn. These models used the logistic regression, decision tree
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and the random forest algorithms. In all three models, the model hyperparameters were
fine tuned to the Cleveland 14 dataset using GridSearchCV. These models though single
layer with no pre-processing, obtained similar results to the studies in the Shouman et
al., Sumathi et al. and Marateb et al. studies shown in Table 2 with our own results as
shown in Table 5. We were able to achieve comparable results with the logistic regres-
sion, decision tree and random forest models.
4.4 Stage 2
The objective in Stage 2 of the research was to improve the stability of the models
used in Stage 1. The small number of observations (297 records) of the Cleveland 14
Dataset which is typical of real healthcare data does not meet volume requirements of
Machine Learning models and will cause instability in the performance metrics results
during 10 fold cross-validation on the Machine Learning models. Therefore, in Stage
2 we generated a 50,000 observation surrogate dataset based on subject characteristics
from the Cleveland 14 dataset. We applied the Synthpop library in R Studio to generate
the surrogate dataset and assessed the same prediction metrics using logistic regression,
decision tree and random forest models.
The Synthpop library was used in R Studio to generate the surrogate dataset. To
show that the surrogate dataset mimics the characteristics of the Cleveland dataset,
all attributes of the synthetic data were compared on frequency plots to the Cleveland
dataset (Figure 5). As an added comparison, the surrogate data were fitted to the general
linear/logistic model used in the Synthpop data synthesis of the Cleveland 14 surrogate
data and the resulting coefficients of the Cleveland 14 and the surrogate data set were
compared and shown to overlap each other with a 95% confidence limit (Figure 2).
4.5 Stage 3
The objective of Stage 3 was to improve the accuracy, precision and recall results from
Stage 2. We used a Perceptron Neural Network Model that was configured with 3 hid-
den layers and 3 dropout layers. Neural Network models, in general, produce higher
accuracy measurements than traditional machine learning models; however, they have
higher data volume training requirements [18]. To satisfy this, we generated a 60,000
record surrogate data set from the raw Cleveland dataset. The surrogate data set has
37 explanatory and one response variable and a shape of 38 X 60,000. To show that
the Cleveland data set characteristics were preserved in the surrogate data set, we used
the Synthpop compare function to plot frequency plots of all the data sets for compari-
son (Figure 5). In addition, the coefficient confidence interval was plotted to show that
both the raw Cleveland dataset and the surrogate dataset coefficients have the same fit
response to the general linear/logistic model used in Synthpop (Figure 3).
5 Results
In Stage 1, the results of our preliminary classification models (logistic regression, deci-
sion tree, and random forest) performed using the Cleveland 14 data set were consistent
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Fig. 2. Cleveland 14 Versus Surrogate Coefficient Confidence Interval Comparison
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Fig. 3. Raw Cleveland Versus Surrogate Coefficient Confidence Interval Comparison
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with results from previous research. Accuracy ranged from 83% - 88% using logistic
regression, 74%-79% using a decision tree classifier, and 77%-81% using a random
forest classifier.
Of the three, the logistic regression model produced superior accuracy prediction
metrics - up to the 88 percent range. The recall metric score for logistic tegression has
a 7 percent variation compared to that of the random forest model with a variation of
11 percent. The stability of the recall metric is of high interest since it is an indication
of the false negative prediction rates. Figure 4 and Table 5 summarizes the accuracy,
precision and recall results for the three models.
Fig. 4. Stage 1 Results: Range of accuracy, precision and recall values for 10-fold cross validation
models for Logistic Regression, Decision Tree, and Random Forest.
Table 5. Stage 1 Machine Learning Metric Results
Machine Learning Model Accuracy Precision Recall
Logistic Regression 83 - 88% 82 - 92% 75 - 82%
Decision Tree 74 - 79% 71 - 75% 69 - 77%
Random Forest 77 - 81% 74 - 84% 70 - 81%
The characteristics of the synthetic data that were generated using the original
Cleveland 14 data set in stage 2 of our analysis shared very similar distributions com-
pared to the original data. The distribution for each variable was reviewed and some
examples are shown in Figure 5.
In stage 2, we applied the logistic regression model to the synthetic Cleveland 14
data in order to determine what the results would be using the same logistic regression
model (as in stage 1) with the surrogate data. The results show that accuracy, precision
15
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Fig. 5. Example Raw Cleveland to Surrogate Frequency Plots for Cholesterol, Chest Pain Type,
Peak Exercise Blood Pressure and Age
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and recall have similar levels between the original Cleveland 14 data in stage 1 versus
the Cleveland 14 Surrogate data in Figure 6. The main difference is that the ranges are
much narrower (within 2 percent) when using the surrogate data indicating a more sta-
ble performance of the logistic regression model when the data volume is significantly
increased.
Fig. 6. Stage 2 results: Logistic Regression Model Accuracy, Precision and Recall Metrics for
Stage 1 (left) compared to Stage 2 (right)
Finally in stage 3, after achieving improved stability with the application of the lo-
gistic regression model to the larger surrogate Cleveland 14 data set as compared to the
original Cleveland 14 data set, we implemented a neural network model (Perceptron)
using an expanded surrogate data set (60,000 samples) based on the raw Cleveland data
set (38 attributes from 76, after data cleaning). Recall that the Cleveland 14 data set from
the UCI Repository used in previous studies (also in stages 1 and 2) was also derived
from the same raw Cleveland data set in this case. The performance of the Perceptron
deep learning model shows the accuracy, precision and recall scores consistently at 96.7
percent with a 1 percent variation shown in Figure 7.
6 Analysis
As shown from the results of the traditional classification models, performance was
consistent with what has been produced with prior studies. This outcome is consistent
with what we expect from reviewing reproducible research and serves as a baseline for
our additional analysis.
The primary focus of our analysis was to examine the synthetic data observations
and compare them to the original observations from the Cleveland data set. We first
looked at the response variable, which is the presence or absence of heart disease. For
the presence of heart disease the Cleveland data set had 44.3 percent positive compared
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Fig. 7. Stage 3 results: Accuracy, Precision and Recall Metrics using Neural Network Perceptron
Model with Surrogate Data.
to 55.7 percent negative. The surrogate data is similarly split with 43.8 percent positive
compared to 56.2 percent negative.
In an effort to compare the mean distribution values, we calculated a 95 percent
confidence interval for the proportion of individuals with heart disease and plotted the
interval ranges in Figure 8. As expected, the variance for the synthetic data is very
small due to the massive amount of observations. However, we find that the mean of the
proportion for the surrogate data set is contained within the confidence interval for the
proportion for the Cleveland data set.
Fig. 8. 95 percent Confidence Interval of Mean Proportion of Heart Disease for Synthetic and
Original Data Sets
Although we did not statistically test the values for the other variables we visually
examine the distributions for each attribute. Those plots for a few of the more familiar
attributes are shown in Figure 5. We are satisfied that the surrogate data set appropri-
ately mimicked the original observations, therefore we used it to build a neural network
model.
As shown in Figure 9, the neural network model built using the surrogate data set
produces superior accuracy precision and recall compared to the traditional logistic
regression models.
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Fig. 9. Stage 1, 2 and 3 Results: Progression of improvement in Accuracy, Precision and Recall
Metrics and Stability for Stage 1 (left), Stage 2 (middle) and Stage 3 (right). Stage 3 shows the
highest scores for all 3 metrics at 96.7 percent with only 1 percent variation.
7 Ethics
Studies involving medical research require careful consideration of ethical concerns.
Addressing those concerns often begins at the design stage of an experiment where a
patient is required to give informed consent to participate in the study. During this stage,
the patient is informed of the purpose of the study, the benefits and risks are explained
and he is asked to voluntarily agree to participate.
However, even after a specific study is concluded, data gathered during the course
of an experiment continues to live. Since much of the purpose of data mining is to iden-
tify previously unseen patterns, utilization of data collected in medical research may
continue for many years and extend beyond original intents of a given study. Patients
are not capable of giving specific consent for use of their information for unforeseen
uses [19].
This motivates the need to protect patient privacy. Although many personally iden-
tifying elements are anonymized in medical research data sets, knowledge of the pa-
tient privacy protections allowed in the Health Insurance Portability and Accountability
Act (HIPAA) of 1996 is critical to ensure compliance. HIPAA very explicitly provides
for patient privacy protection by requiring de-identification of Protected Health Infor-
mation (PHI). PHI describes any data element which could allow identification of the
individual for which the health information pertains to. The following is the definition
from the Code of Federal Regulations that defines health information subject to privacy
protection [22].
From 45 CFR 160.103
Health information means any information, including genetic information,
whether oral or recorded in any form or medium, that:
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(1) Is created or received by a health care provider, health plan, public health
authority, employer, life insurer, school or university, or health care clearinghouse;
and
(2) Relates to the past, present, or future physical or mental health or condition
of an individual; the provision of health care to an individual; or the past, present,
or future payment for the provision of health care to an individual.
PHI must be removed from medical research data or masked to ensure patient pri-
vacy is protected under HIPAA. As stated in the description, this goes beyond anonymiz-
ing patient numbers and names. Any data element, or combination of data elements, that
could reasonably be linked to an individual, including genetic data, is included in this
measure.
To make data from medical research available, only the minimal necessary informa-
tion should be disclosed. Although it can be difficult to determine the threshold for the
minimally necessary information for each use, CFR 164 [23] contains an extensive list-
ing of information elements that are potential identifiers and should be excluded from
all data sets as shown in Table 6.















Full face photographic images
Web URLs
We view the opportunity to create surrogate data sets as a potential solution to min-
imize the risk of disclosing any potential individual identifying data related to medical
research. Because the surrogate data is comprised of synthetic observations, there is
no disclosure of any true patient identifying elements. The surrogate data sets would
mimic the original observations. Depending upon the research purpose and analytic
tools used, surrogate data sets of varying sizes can be generated. However, caution
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should be taken to ensure that surrogate data sets are not used beyond research objec-
tives and researchers should be transparent regarding the use of synthetic data.
8 Future Work
The use of surrogate data to train machine and deep learning models in this study ap-
pears to be an effective step towards improving heart disease prediction, but with limi-
tations. The origin of the patient data used in this study was from the Cleveland, Ohio
area and is not geographically diverse. From a global perspective, each geographical
region has its own characteristic diet, lifestyle and availability of healthcare resources.
According to the World Health Organization, in 2017, Turkmenistan had the highest
death rate due to cardiovascular disease at 411.1 deaths per 100,000 while South Korea
has the lowest at 30.76 [4]. Application of surrogate data in heart disease prediction us-
ing machine or deep learning techniques with patient data from geographically diverse
sources would be interesting to explore in the future. By doing so, we can potentially
discover data patterns that are not easily seen by using a geographically focused patient
data set such as the Cleveland data set.
9 Conclusions
We find that the Synthpop package produces an adequate surrogate set of synthetic
data which closely mimics the characteristics of the original observations. Our analysis
shows, by comparison, that classification prediction outcomes from traditional machine
learning models such as logistic regression, are reasonably similar whether the surrogate
data set or the original observations are used. Variability of the prediction measurements
are improved, in this case, due to the increased number of observations in the surrogate
data set.
In addition, we improved heart disease prediction using surrogate data. Due to the
large volume of synthetic observations that can be produced, the surrogate data are
suitable for use with deep learning models such as ANN. Creating synthetic observa-
tions upon which the neural network can be trained and tested allows for an increase in
classification prediction of nearly 16 percent.
These findings provide a basis for additional testing to be performed with other
small clinical data sets. The use of surrogate data as a means to anonymize sensitive data
and potential to improve classification prediction is a worthwhile area for additional
exploration and research.
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